A non-profit organization dedicated to saving the lives of mothers and babies in 2019 A walking event was held on May 19 to raise people's awareness of preeclampsia. The "Hope Trip" for preeclampsia took place at Dick Nichols Park in southwest Austin, concurrently with about 40 other walking events across the country.
Preeclampsia or pregnancy-induced hypertension occurs during pregnancy and affects the health of mothers and babies. Symptoms include high blood pressure and proteinuria, which can be fatal.
"To be honest, I didn't know anything about preeclampsia until it happened to me, and it might be too late.”Leah Bahrencu during the walking activity said, “For me, there is really no way to stand here and explain to everyone the understanding of preeclampsia.”
The KXAN investigation team found that Texas did not track the number of mothers who died due to pregnancy or childbirth complications. In that report, Bahrencu shared her story. "I feel that I have never been educated about preeclampsia. I read all the baby books and blogs and found that many mothers like me have not received this education. We need to know that this is true. Scary, but we are not alone, because when you experience such a thing, you will feel very lonely."Bahrencu said.
She gave birth to twin boys and girls at 34 weeks of pregnancy.当At that time, she was in a coma for 10 days because her lungs, liver and kidneys all stopped working.She and her children survived. Although it was a terrible experience, she used it to educate others.She said: "Once I become better, I need to help others. I need a supportive group of women to support these people who have the same experience as me.”This is why she found the Preeclampsia Foundation.
Bahrencu recently went to the Mothers Congress in Washington, DC, where women from across the country worked together to promote changes in policies that affect mothers. She said that as a local representative, she is here to tell everyone that mothers are not only concerned about passing preeclampsia legislation, but also about pregnant women's mental health, hygiene, and postpartum care.
"Don't be afraid to share your story."Bahrencu said in a message to mothers and expectant mothers. "If you can’t share your story, please tell it to the people around you so that they can share these things for you, because professional doctors can give advice, but in fact, these stories are told from people who have experienced it. Come out to be more powerful."
The funds raised in this walking event will be used to support research, educate mothers about dangerous situations, improve mothers’ medical care and raise their awareness of relevant issues. According to this non-profit organization, the cause of preeclampsia is not yet fully understood, and the only“cure"the only way is through childbirth.
Preeclampsia and PlGF
Preeclampsia is a serious pregnancy complication characterized by high blood pressure and proteinuria. It is one of the main reasons affecting the health of mothers and babies worldwide.Once a pregnant woman has preeclampsia, hypertension, edema, and proteinuria will occur, and it will affect the functions of some important organs. As blood pressure rises further, dangerous events such as convulsions, cerebral hemorrhage, acute kidney injury, and acute heart failure will occur, which seriously threaten the safety of mothers and babies.
In recent years, research has found that placental growth factor (PlGF) is the most specific biochemical marker for predicting preeclampsia.The detection of PlGF and other indicators screened out high-risk pregnant women, who started taking a small dose of aspirin at 11-14 weeks of gestation, which can effectively reduce the incidence of preeclampsia and improve the prognosis of mothers and babies.
Aucheer iRaTe PlGF detection reagent
Placental growth factor (PlGF) is a vascular endothelial growth factor（VEGF）one of the family members, also known as placental-derived angiogenic factor. In pregnant women with preeclampsia, the PlGF concentration is significantly reduced.
The Aucheer iRate PlGF test reagent can help clinicians more reasonably carry out risk stratification and clinical assessment management for high-risk and suspected preeclampsia pregnant women.
Early screening and prevention throughout pregnancy to ensure the safety of mothers and babies
